Trial Profile
Entecavir versus lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Lamivudine
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 19 Dec 2015 New trial record